Michael W. Tusche
Private Equity Investor bei Tio Bioventures
Profil
Dr. Michael Tusche is a Partner at TIO Bioventures, a Biotechnology focused venture creation fund.
He brings over a decade of experience as a Scientist, Investor and Entrepreneur in the Biotech Space.
Previously, Michael was the Chief Scientific Officer and Co-Founder of Nirsum Laboratories, Inc., a startup Biotechnology company developing small molecule therapeutics for Neuroscience indications.
At Nirsum, Dr. Tusche was the Co-inventor of the company’s foundational Intellectual Property and a Principal Investigator of an NIH/NIDA grant, funding the company’s operations into mid-stage clinical studies.
Prior to Nirsum, Michael was the Senior Biotechnology Analyst at Mountain Brook Capital Management, LLC, a Healthcare focused Long/Short equity only Hedge Fund, where his focus was Investments in publicly listed Biopharmaceutical companies.
Before Mountain Brook, Dr. Tusche was an Associate at MLV and Co., a boutique investment bank with a focus on capital raising and advisory work for Life Science based companies.
Dr. Tusche also led Biologic drug discovery at the Campbell Family Institute in Toronto, Canada, where he managed a multidisciplinary R&D team in the pre-clinical development and validation of novel drug candidates.
Michael started his career as a Scientist in drug discovery at Bayer AG in Japan, where he worked on early stage development of small molecule GPCR antagonists for allergic and inflammatory diseases.
Dr. Tusche received his B.Sc.
(with Distinction) in Biochemistry from the University of Victoria.
He also received a Ph.D.
in Immunology from the University of Toronto where he trained in the laboratory of Dr. Tak Mak.
Michael received his M.B.A.
from the University of Toronto.
He is co-author on several peer-reviewed publications, the recipient of numerous scientific and business awards, and named inventor on issued US patents focusing on small molecule and biologic therapeutics.
Aktive Positionen von Michael W. Tusche
Unternehmen | Position | Beginn |
---|---|---|
Tio Bioventures
Tio Bioventures Investment ManagersFinance Tio Bioventures (Tio Bioventures) is a venture capital firm founded in 2019 by Tak Wah Mak and Shane Burgess. The firm is headquartered in New York. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Michael W. Tusche
Unternehmen | Position | Ende |
---|---|---|
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | Vorstandsvorsitzender | 08.12.2023 |
Nirsum Laboratories, Inc.
Nirsum Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Nirsum Laboratories, Inc. is a company based in New York, NY. Nirsum Laboratories, Inc. was founded by Michael W. Tusche, Nikej Shah. The CEO is Nikej Shah. | Gründer | 31.12.2019 |
University Health Network
University Health Network Hospital/Nursing ManagementHealth Services University Health Network operates as a healthcare and medical research organization that provides patient care, education, and research services. Its programs include arthritis program, joint department of medical imaging, Krembil neuroscience center, laboratory medicine program, medical and community care, multi-organ transplant, Peter Munk cardiac center, Princess Margaret cancer, surgery and critical care program, and Toronto rehab. The company was founded in 1986 and is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | 31.10.2013 |
Ausbildung von Michael W. Tusche
Rotman School of Management | Masters Business Admin |
University of Toronto | Doctorate Degree |
University of Victoria | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
University Health Network
University Health Network Hospital/Nursing ManagementHealth Services University Health Network operates as a healthcare and medical research organization that provides patient care, education, and research services. Its programs include arthritis program, joint department of medical imaging, Krembil neuroscience center, laboratory medicine program, medical and community care, multi-organ transplant, Peter Munk cardiac center, Princess Margaret cancer, surgery and critical care program, and Toronto rehab. The company was founded in 1986 and is headquartered in Toronto, Canada. | Health Services |
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | Health Technology |
Tio Bioventures
Tio Bioventures Investment ManagersFinance Tio Bioventures (Tio Bioventures) is a venture capital firm founded in 2019 by Tak Wah Mak and Shane Burgess. The firm is headquartered in New York. | Finance |
Nirsum Laboratories, Inc.
Nirsum Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Nirsum Laboratories, Inc. is a company based in New York, NY. Nirsum Laboratories, Inc. was founded by Michael W. Tusche, Nikej Shah. The CEO is Nikej Shah. | Health Technology |